The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins

Microbial Pathogenesis

Volumn 40, Issue 6, 2006, Pages 254-260

  Soares, N M ^a,b   Ferraz, T P L ^a,b   Nascimento, E G ^c   Carvalho, E M ^b   Pontes de Carvalho, L ^a,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Secretaria da Saude do Estado da Bahia   (Brazil)

^d ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

IgG; Immune complexes; Immunosuppression; Leishmania; Lymphocyte; Lipoproteins

Indexed keywords

CONCANAVALIN A; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; PROTEIN A; PROTEIN G; SOLUBLE INTERLEUKIN 2 RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ANION EXCHANGE CHROMATOGRAPHY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MOLECULAR WEIGHT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS; ANIMAL; BLOOD; DRUG EFFECT; IMMUNE DEFICIENCY; IMMUNOLOGY; LEISHMANIA INFANTUM; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CONCANAVALIN A; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LYMPHOCYTE ACTIVATION;

EID: 33746833723     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2006.02.005     Document Type: Article

References (32)

1. Lainson R., and Shaw J.J. The leishmaniases. Part 1. Evolution, classification and geographical distribution (1987.), Academic Press, London p. 27-65
2. Carvalho E.M., Andrews B.S., Martinelli R., Dutra M., and Rocha H. Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis. Am J Trop Med Hyg 32 1 (1983) 61-68
3. Barral A., Carvalho E.M., Badaró R., and Barral-Netto M. Suppression of lymphocyte proliferative responses by sera from patients with American visceral leishmaniasis. Am J Trop Med Hyg 35 (1986) 735-742
4. Carvalho E.M., and Bacellar A.O. Lymphocyte reactivity to mitogens in American visceral leishmaniasis. Braz J Med Biol Res 16 (1983) 35-41
5. Guerreiro J., Ribeiro S., Carvalho E.M., Badaro R., and Rocha H. Bacterial infection in patients with visceral leishmaniasis. Mem Inst Oswaldo Cruz 80 4 (1985) 447-452
6. Barral-Neto M., and Barral A. A simple method for assessing the binding of concanavalin a to mononuclear cell surfaces: no interference of visceral leishmaniasis serum on this binding. Mem Inst Oswaldo Cruz 81 3 (1986) 343-345
7. Brooks W.H., Netsky G.M., Normansell D.E., and Horwitz D.A. Depressed cell-mediated immunity in patients with primary intracranial tumors. J Exp Med 136 (1972) 1631-1647
8. Cottrell B.J., Huber D., and Sturrock R.F. An immunosuppressive factor in the serum of patients with schistosomiasis. Trans R Soc Trop Med Hyg 74 (1980) 415-419
9. Londner M.V., Frankenburg S., Slutzky G.M., and Greenblatt C.L. Action of leishmanial excreted factor (EF) on human lymphocyte blast transformation. Parasite Immunol 5 (1983) 249-256
10. Curtiss L.K., and Edgington T.S. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol 116 (1976) 1452-1458
11. Barral-Netto M., Barral A., Santos S.B., Carvalho E.M., Badaró R., Rocha H., et al. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 147 (1991) 281-284
12. Cunninghan D., and Kunn R.E. Trypanosoma cruzi induced suppressor substances. Part I. Cellular involvement and partial characterization. J Immunol 124 (1980) 2122-2126
13. Wyler D.J. Circulating factor from a kala-azar patient suppresses in vitro antileishmanial T cell proliferation. Trans R Soc Trop Med Hyg 76 (1982) 304-306
14. Lammie P.J., Katz S.P., and Anderson W.H.K. Serosuppression in experimental filariasis. Clin Exp Immunol 55 (1984) 602-610
15. Cox R.A., and Pope R.M. Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis. Infect Immun 55 (1987) 1058-1062
16. Mehra V.L., Talwar G.P., Galakrisnan K., and Bhutani L.K. Influence of chemoteraphy and serum factors on the mitogenic response of peripheral leucocytes of leprosy patients to phytohemaglutinin. Clin Exp Immunol 12 (1972) 205-213
17. Dorval G., Yang W.H., Goodfriend L., Roy R., Espinoza L.R., and Hebert J. Circulating immune complexes may be associated with increased suppressor T-cell activity in atopic allergy. Clin Immunol Immunopathol 16 (1980) 245-253
18. Sulica A., Galatiuc C., Manciulea M., Deleo A., Bancu A.C., Whiteside T.L., et al. Regulation of human natural cytotoxicity by IgG. IV. Association between of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity. Cell Immunol 147 (1993) 397-410
19. Vital G., Mansueto S., Malta R., Gambino G., Mocciaro C., D'Agostino R., et al. The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients. Clin Exp Immunol 90 (1992) 219-222
20. Chisari F.V. Immunoregulatory properties of human plasma in very low density lipoproteins. J Immunol 119 (1977) 2129-2135
21. Morse J.J., Witte L.D., and Goodman D.S. Inhibition of lymphocyte proliferation stimulated by lectins and allogenic cells by normal plasma lipoprotein. J Exp Med 146 (1977) 1791
22. Waddell C.O., Taunton O.D., and Twomey J.J. Inhibition of lymphoproliferation by hyperlipoproteinemia plasma. J Clin Invest 58 (1976) 950-954
23. Cuthbert J.A., and Lipsky P.E. Differential regulation of the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor genes. J Lipid Res 33 (1992) 1157-1163
24. Yi P.I., Beck G., and Zucker S. Membrane receptors for very low density lipoprotein (VLDL) inhibitor of lymphocyte proliferation. Blood 57 (1981) 1055-1064
25. Arya S.K., Wong-Stall F., and Gallo R.C. Dexamethasone mediated inhibition of human T cell growth factor and gamma interferon messenger RNA. J Immunol 133 (1984) 273-276
26. Cooperbnad S.R., Badger A.M., Davis R.C., Schimd K., and Mannick J.A. The effect of immunoregulatory & globulin (IRA)upon lymphocytes in vitro. J Immunol 109 (1972) 154-163
27. Sathish M., Bhutani L.K., Sharma A.K., and Nath I. Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy. Infect Immun 42 (1983) 890-899
28. Attar Z.A., Chance M.L., El-Safi S., Carney J., Azazy A., El-Hadi M., et al. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop 78 (2001) 11-16
29. Azazy A.A. Detection of circulating antigens in sera from visceral leishmaniasis patients using dot-ELISA. J Egypt Soc Parasitol 34 1 (2004) 35-43
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277 (1970) 680-685
31. Soares N.M., Santiago M.B., and Pontes de Carvalho L.C. An improved anti-C3/IgG ELISA for quantification of soluble immune complexes. J Immunol Methods 249 (2001) 199-205
32. Redgrave T.G., Roberts D.C.K., and West C.E. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 65 (1975) 42-49